Relationship between lncRNA MALAT1 and Chemo-radiotherapy Resistance of Cancer Cells: Uncovered Truths
- PMID: 38806965
- DOI: 10.1007/s12013-024-01317-6
Relationship between lncRNA MALAT1 and Chemo-radiotherapy Resistance of Cancer Cells: Uncovered Truths
Abstract
The advancement of novel technologies, coupled with bioinformatics, has led to the discovery of additional genes, such as long noncoding RNAs (lncRNAs), that are associated with drug resistance. LncRNAs are composed of over 200 nucleotides and do not possess any protein coding function. These lncRNAs exhibit lower conservation across species, are typically expressed at low levels, and often display high specificity towards specific tissues and developmental stages. The LncRNA MALAT1 plays crucial regulatory roles in various aspects of genome function, encompassing gene transcription, splicing, and epigenetics. Additionally, it is involved in biological processes related to the cell cycle, cell differentiation, development, and pluripotency. Recently, MALAT1 has emerged as a novel mechanism contributing to drug resistance or sensitivity, attracting significant attention in the field of cancer research. This review aims to explore the mechanisms through which MALAT1 confers resistance to chemotherapy and radiotherapy in cancer cells.
Keywords: Cancer; Chemo-radiotherapy; LncRNA; MALAT1; Resistance.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
LncRNA MALAT1 Depressed Chemo-Sensitivity of NSCLC Cells through Directly Functioning on miR-197-3p/p120 Catenin Axis.Mol Cells. 2019 Mar 31;42(3):270-283. doi: 10.14348/molcells.2019.2364. Epub 2019 Feb 19. Mol Cells. 2019. PMID: 30841025 Free PMC article.
-
Multiple function of lncRNA MALAT1 in cancer occurrence and progression.Chem Biol Drug Des. 2023 May;101(5):1113-1137. doi: 10.1111/cbdd.14006. Epub 2022 Jan 31. Chem Biol Drug Des. 2023. PMID: 34918470 Review.
-
Long non-coding RNAs in cancer drug resistance development.DNA Repair (Amst). 2016 Sep;45:25-33. doi: 10.1016/j.dnarep.2016.06.003. Epub 2016 Jun 30. DNA Repair (Amst). 2016. PMID: 27427176 Review.
-
The implication of LncRNA MALAT1 in promoting chemo-resistance of laryngeal squamous cell carcinoma cells.J Clin Lab Anal. 2020 Apr;34(4):e23116. doi: 10.1002/jcla.23116. Epub 2019 Dec 14. J Clin Lab Anal. 2020. PMID: 31837057 Free PMC article.
-
Long non-coding RNA (lncRNA) PVT1 in drug resistance of cancers: Focus on pathological mechanisms.Pathol Res Pract. 2024 Feb;254:155119. doi: 10.1016/j.prp.2024.155119. Epub 2024 Jan 11. Pathol Res Pract. 2024. PMID: 38309019 Review.
Cited by
-
Radio-chemotherapy and metformin selectively modulate the heterogeneous landscape of glioma with ribosome biogenesis, long non coding RNA and immune-escape markers as major player.Int J Biol Sci. 2025 May 27;21(8):3527-3554. doi: 10.7150/ijbs.103194. eCollection 2025. Int J Biol Sci. 2025. PMID: 40520013 Free PMC article.
-
Investigation of Non-Coding RNA-Related Autophagy Alterations in Drug-Resistant Multiple Myeloma Plasma Cells.Iran J Pathol. 2024 Fall;19(4):422-430. doi: 10.30699/ijp.2024.2022061.3256. Epub 2024 Oct 2. Iran J Pathol. 2024. PMID: 40034935 Free PMC article.
-
Gene expression profiling of lncRNA-HOTAIR and lncRNA-MALAT1 in esophageal cancer: uncovering links to lifestyle factors and diagnostic significance.Discov Oncol. 2025 Apr 28;16(1):630. doi: 10.1007/s12672-025-02465-8. Discov Oncol. 2025. PMID: 40295320 Free PMC article.
References
-
- Kokka, F., Bryant, A., Olaitan, A., Brockbank, E., Powell, M., & Oram, D. (2022). Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. The Cochrane Database of Systematic Reviews, 8, Cd010260 - PubMed
-
- Hickey, B. E., Francis, D. P., Lehman, M. (2013). Sequencing of chemotherapy and radiotherapy for early breast cancer. Cochrane Database Systematic Reviews. 30, Cd005212.
-
- Haussmann, J., Tamaskovics, B., Bölke, E., Djiepmo-Njanang, F. J., Kammers, K., & Corradini, S., et al. (2019). Addition of chemotherapy to hyperfractionated radiotherapy in advanced head and neck cancer-a meta-analysis. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft, 195, 1041–1049. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical